synthetic drugs

Webinar: "Synthetic Drug Threats in the United States: 2018 Update"

Webinar, United States,

The NDEWS Coordinating Center has announced that Jill Head, Supervisory Chemist at the DEA Special Testing and Research Laboratory, will deliver the webinar "Synthetic Drug Threats in the United States: 2018 Update" on February 28 at 2:00 pm EST to provide an update on synthetic drug threats in the United States. Her previous presentations have provided valuable information on emerging trends.

Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health

Citation
Weinstein AM, Rosca P, Fattore L and London ED (2017) Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health. Front. Psychiatry 8:156. doi: 10.3389/fpsyt.2017.00156
Publication Date

As part of an increasing worldwide use of designer drugs, recent use of compounds containing cathinones and synthetic cannabinoids is especially prevalent. Here, we reviewed current literature on the prevalence, epidemiology, bio-behavioral effects, and detection of these compounds. Gender differences and clinical effects will also be examined.

Synthetic Drugs on the Rise in Afghanistan

Seizures of methamphetamine have increased in Afghanistan, according to a new report from the United Nations drug and crime agency. It also suggests that the drug is being produced inside the country. The UN Office on Drugs and Crime (UNODC) has concluded that “there are strong indications that methamphetamine use is establishing itself among opiate users, which are already one of the most vulnerable parts of Afghan society.” This new evidence suggests synthetic drugs are

Webinar "Synthetic Drug Threats in the United States: 2017 Update"

College Park, United States,

Event Date and Time: 

Wednesday, February 15, 2017 - 2:00pm to 4:00pm

Presentation: Synthetic Drug Threats in the United States: 2017 Update 
Presenter: Jill M. Head, Supervisory Chemist,
DEA Special Testing and Research Laboratory

Lethal Highs: How U.S. Customs and Border Protection Laboratories Are Protecting America from Designer Drugs

Published by
U.S. Department of Homeland Security, Customs and Border Protection
Publication Date

This article summarizes the work of the U.S. Department of Homeland Security Customs and Border Protection agency (CBP) in the area of counternarcotics. The CBP describes the challenges to addressing substance use when molecular manipulation is being used by drug manufacturing chemists.